Saturday, October 31, 2026

Is Coupang’s Data Breach Investigation Threatening Korea-U.S. Security Cooperation?

South Korea's government asserts security talks with the U.S. will not be influenced by Coupang's issues, amid investigations and U.S. demands.

HLB Pep Signs Deal with Japan’s ReproCELL to Supply Customized Neoantigen Peptides — The Future of Precision Medicine?

HLB PEP partners with Reprocell to supply customized neo-antigen peptides for personalized cancer treatment, targeting global markets.

Coupang Data Breach: How an ISDS Claim Could Spark an International Dispute

Coupang faces international arbitration over a data breach, with U.S. shareholders claiming unfair treatment by South Korea's government.

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.
Latest

Hanmi Pharmaceutical to Present Phase 2 Clinical Results for Congenital Hyperinsulinism Treatment at European Conference

Hanmi Pharmaceutical will present Phase 2 data on its investigational treatment efpeglenatide (HM15136) for congenital hyperinsulinism at the 64th European Society for Paediatric Endocrinology meeting in France.

“It’s Not Just a Women’s Issue”: Men Also Face Osteoporosis Risk With Age-Related Hormone Decline

Men with low testosterone and vitamin D levels face a significantly higher risk of reduced hip bone density, a study found.

Skylabs Lists on KOSDAQ, Aiming to Become Global Medical Data Platform

Skylabs has listed on the KOSDAQ market, accelerating its global expansion while broadening its business from blood pressure monitoring to multivital monitoring and medical data.

Curocell’s ‘Lymcato’ Clears Review for National Health Insurance Coverage

Curocell’s CAR-T therapy Lymcato has passed the Health Insurance Review and Assessment Service’s drug reimbursement review, accelerating its path toward national health insurance coverage this year.

Why Severance Hospital Dominates the Korean Wellness Index for 20 Consecutive Years?

Severance Hospital has ranked first in the Korean Wellness Index for hospitals for 20 consecutive years, showcasing its excellence.

Celtrion’s Steqeyma Seizes 16% Market Share in the U.S.: What’s Next for This Autoimmune Treatment?

Celltrion's autoimmune drug Steqeyma surpasses 16% market share in the U.S., accelerating prescription growth and expansion.

Pharos iBio and Kolon Pharmaceutical Expand Joint Development of Lung Cancer Drug

Pharos iBio and Kolon Pharmaceutical are stepping up development of PHI-701, a next-generation EGFR inhibitor targeting patients who have developed resistance to existing targeted lung cancer treatments.

Rokit Healthcare Secures Singapore Patent for Skin Regeneration Patch Technology

Rokit Healthcare has secured a Singapore patent for a personalized skin regeneration patch technology and plans to use the country as a base for expanding into Southeast Asia’s regenerative medicine market.

Samsung Seoul Hospital Performs 1 in 5 Gastric Cancer Surgeries With Robots

Samsung Seoul Hospital has performed 1,500 cumulative robotic gastric cancer surgeries, with robot-assisted procedures accounting for 22% of all gastric cancer surgeries last year.

Alteogen Signs Subcutaneous Injection Development Deal With Novartis Worth Up to $3.22 Billion

Alteogen has signed an option and licensing agreement with Novartis to develop and commercialize subcutaneous formulations based on its ALT-B4 technology, with potential payments of up to $3.22 billion plus royalties.

How Mediwhale’s Dr. Noon CVD Uses AI to Revolutionize Cardiovascular Risk Assessment

Mediwhale presents clinical applications of retinal image analysis for cardiovascular risk assessment at the European Cardiology Congress.

JAYJUN Wins China’s No. 1 Mask Pack Brand of the Year for 10th Consecutive Year

JAYJUN has retained the top spot in China’s mask pack category for 10 consecutive years and received the Masterpiece award recognizing its decade-long winning streak.

SK Biopharmaceuticals Introduces 128 NVIDIA B200 GPUs, Accelerating AI-Driven Drug Discovery

SK Biopharmaceuticals has secured 128 NVIDIA B200 GPUs to build large-scale AI infrastructure, accelerate AI-driven drug discovery, strengthen TR-AX, and explore new AI-based research business models.

Asia MSD Applies for Fast-Track Listing Pilot Program for Pulmonary Arterial Hypertension Drug Winrevair

Asia MSD has applied to a government fast-track listing pilot program aimed at accelerating National Health Insurance coverage for Winrevair, a novel pulmonary arterial hypertension treatment.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.